1h Free Analyst Time
The orthopedic soft tissue repair devices market is forecasted to grow by USD 6392.62 mn during 2023-2028, accelerating at a CAGR of 11.28% during the forecast period. The report on the orthopedic soft tissue repair devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising geriatric population across the globe, the rise in the frequency of sports-related injuries, and the increase in accident and trauma cases.
The orthopedic soft tissue repair devices market is segmented as below:
By Product Type
- Fixation devices
- Tissue scaffold
- Cell therapy-based
By End-user
- Hospitals and clinics
- Ambulatory surgical centers (ASCs)
- Physician office
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the orthopedic soft tissue repair devices market covers the following areas:
- Orthopedic soft tissue repair devices market sizing
- Orthopedic soft tissue repair devices market forecast
- Orthopedic soft tissue repair devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global orthopedic soft tissue repair devices market: Acera Surgical Inc., AlloSource, Amplitude SAS, Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Zimmer Biomet Holdings Inc., and Arthrex Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing use of orthopedic devices in emerging market.'
According to the report, one of the major drivers for this market is the rising geriatric population across globe.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acera Surgical Inc.
- AlloSource
- Amplitude SAS
- Becton Dickinson and Co.
- Boston Scientific Corp.
- Conmed Corp.
- Integra Lifesciences Corp.
- Johnson and Johnson
- JRF Ortho
- LifeCell International Pvt. Ltd.
- LifeNet Health Inc.
- Medtronic Plc
- MTF Biologics
- RTI Surgical Inc.
- Smith and Nephew plc
- Stryker Corp.
- Tissue Regenix Group Plc
- Zimmer Biomet Holdings Inc.
- Arthrex Inc.
